AN2 <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc. Executes Share Exchange Agreements with Coastlands Capital, Issuing Pre-Funded Warrants for 2.8 Million Shares
AN2 Therapeutics Inc. has engaged in share transactions with Coastlands Capital Partners LP. On June 17, 2025, Coastlands Capital exchanged 2,500,000 shares of the company's common stock for a pre-funded warrant to acquire an equivalent number of shares. Similarly, on June 19, 2025, 300,000 shares of common stock were exchanged for a pre-funded warrant to acquire 300,000 shares. The pre-funded warrants have an exercise price of $0.00001 per share and are exercisable at any time until fully exercised.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-143187), on June 20, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。